Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Christopher Wardell

Concepts (266)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
39
2025
3082
1.920
 Why?
Mutation
21
2022
1337
1.620
 Why?
High-Throughput Nucleotide Sequencing
5
2021
180
0.940
 Why?
Translocation, Genetic
14
2021
266
0.910
 Why?
Whole Body Imaging
1
2025
25
0.890
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2025
41
0.880
 Why?
Image Processing, Computer-Assisted
1
2025
235
0.810
 Why?
Oncogenes
2
2018
61
0.680
 Why?
Bone and Bones
1
2025
501
0.680
 Why?
Tomography, X-Ray Computed
1
2025
1180
0.610
 Why?
Biliary Tract Neoplasms
1
2018
5
0.550
 Why?
Cholangiocarcinoma
1
2018
27
0.550
 Why?
Gene Expression Profiling
14
2022
1112
0.540
 Why?
Genomics
8
2022
271
0.510
 Why?
Proto-Oncogene Proteins B-raf
3
2022
78
0.490
 Why?
Gene Expression Regulation, Neoplastic
11
2022
868
0.480
 Why?
Prognosis
15
2021
2118
0.390
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2020
1043
0.360
 Why?
Gene Dosage
5
2020
76
0.360
 Why?
Brain Neoplasms
3
2023
319
0.360
 Why?
Humans
52
2025
53230
0.360
 Why?
Genetic Predisposition to Disease
5
2018
533
0.350
 Why?
Plasma Cells
4
2021
234
0.350
 Why?
Genome, Human
4
2021
121
0.330
 Why?
Evolution, Molecular
2
2021
97
0.330
 Why?
Liver Neoplasms
3
2022
346
0.330
 Why?
DNA Mutational Analysis
7
2020
179
0.320
 Why?
Thalidomide
5
2019
378
0.310
 Why?
DNA Copy Number Variations
4
2021
117
0.300
 Why?
In Situ Hybridization, Fluorescence
11
2023
266
0.300
 Why?
Software
2
2021
280
0.280
 Why?
Monoclonal Gammopathy of Undetermined Significance
4
2017
123
0.270
 Why?
Neoplasm Recurrence, Local
3
2021
647
0.260
 Why?
Aged
16
2025
10429
0.260
 Why?
Chromosome Aberrations
6
2022
297
0.260
 Why?
Carcinoma, Hepatocellular
2
2022
212
0.250
 Why?
Polymorphism, Single Nucleotide
3
2018
505
0.250
 Why?
Middle Aged
18
2025
13419
0.250
 Why?
Male
26
2025
27435
0.240
 Why?
Female
27
2025
28782
0.240
 Why?
Clonal Evolution
2
2019
59
0.230
 Why?
Epigenesis, Genetic
4
2018
412
0.230
 Why?
Chromosomes, Human, Pair 1
2
2019
95
0.230
 Why?
Immunoglobulin Heavy Chains
3
2014
46
0.230
 Why?
Neoplasm Proteins
3
2017
330
0.220
 Why?
Disease Progression
8
2021
880
0.210
 Why?
Gene Regulatory Networks
2
2022
112
0.210
 Why?
Lymphoma, B-Cell, Marginal Zone
1
2023
24
0.200
 Why?
Polycomb Repressive Complex 2
2
2021
48
0.190
 Why?
Chromosomes, Human, Pair 14
5
2014
76
0.190
 Why?
Central Nervous System Neoplasms
1
2023
69
0.190
 Why?
Exome
4
2017
54
0.190
 Why?
Hematologic Neoplasms
1
2023
101
0.180
 Why?
STAT2 Transcription Factor
1
2021
6
0.180
 Why?
STAT1 Transcription Factor
1
2021
28
0.180
 Why?
Germ-Line Mutation
2
2021
67
0.180
 Why?
Li-Fraumeni Syndrome
1
2021
11
0.180
 Why?
Genome-Wide Association Study
3
2018
184
0.180
 Why?
Japan
2
2018
42
0.170
 Why?
Gene Frequency
2
2017
97
0.160
 Why?
Aged, 80 and over
9
2021
3494
0.160
 Why?
Cell Cycle
1
2021
237
0.160
 Why?
Neoplasms
2
2020
1334
0.160
 Why?
Glioblastoma
1
2021
101
0.160
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
 Why?
Leukemia, Plasma Cell
1
2020
35
0.160
 Why?
DNA Methylation
3
2016
592
0.160
 Why?
Ecosystem
1
2021
99
0.160
 Why?
Chromosomal Instability
1
2019
16
0.150
 Why?
Genes, myc
1
2019
39
0.150
 Why?
Chromosomes, Human, Pair 4
3
2014
30
0.150
 Why?
Cell Survival
2
2018
600
0.140
 Why?
Diploidy
2
2017
25
0.140
 Why?
Chromosomes, Human, Pair 11
3
2014
56
0.140
 Why?
INDEL Mutation
1
2018
4
0.140
 Why?
Genes, Tumor Suppressor
2
2021
73
0.140
 Why?
Mutagenesis
1
2018
59
0.140
 Why?
Genes, Immunoglobulin Heavy Chain
2
2019
13
0.140
 Why?
Italy
1
2018
27
0.140
 Why?
Adult
13
2021
14534
0.140
 Why?
Transcriptional Elongation Factors
1
2017
17
0.130
 Why?
Histone-Lysine N-Methyltransferase
2
2016
56
0.130
 Why?
Chromosomes, Human, Pair 5
1
2017
17
0.130
 Why?
Enhancer Elements, Genetic
1
2017
60
0.130
 Why?
Reproducibility of Results
1
2021
1219
0.130
 Why?
Melanoma
1
2020
277
0.130
 Why?
Transcriptome
4
2021
367
0.130
 Why?
Chromosomes, Human
1
2017
41
0.130
 Why?
Hepatocytes
1
2018
188
0.130
 Why?
Immunologic Factors
1
2017
117
0.120
 Why?
B-Lymphocytes
2
2016
178
0.120
 Why?
Neoplasms, Multiple Primary
1
2016
44
0.120
 Why?
Neoplasm Metastasis
1
2016
237
0.120
 Why?
Melphalan
2
2013
180
0.120
 Why?
Oligodendroglioma
1
2015
6
0.120
 Why?
Sequence Analysis, DNA
2
2016
216
0.110
 Why?
Skin Neoplasms
1
2020
500
0.110
 Why?
ras Proteins
1
2015
64
0.110
 Why?
Endoribonucleases
1
2015
17
0.110
 Why?
Survival Rate
4
2020
949
0.110
 Why?
Basic Helix-Loop-Helix Transcription Factors
1
2015
42
0.110
 Why?
Survival Analysis
5
2015
659
0.110
 Why?
Endoplasmic Reticulum Stress
1
2015
51
0.110
 Why?
SMN Complex Proteins
1
2014
4
0.110
 Why?
RNA Processing, Post-Transcriptional
1
2014
23
0.110
 Why?
Signal Transduction
5
2022
1748
0.110
 Why?
Transcription Factors
2
2015
571
0.110
 Why?
Mutation Rate
3
2021
36
0.110
 Why?
Chromosome Deletion
2
2011
138
0.110
 Why?
Cyclin D
1
2013
18
0.100
 Why?
Kaplan-Meier Estimate
4
2018
487
0.100
 Why?
Genes, erbB-1
1
2013
9
0.100
 Why?
Nerve Tissue Proteins
1
2015
193
0.100
 Why?
RNA, Neoplasm
1
2013
45
0.100
 Why?
Cell Line, Tumor
4
2022
1470
0.100
 Why?
Repressor Proteins
1
2014
149
0.100
 Why?
Chromosome Breakage
1
2013
16
0.100
 Why?
Precursor Cells, B-Lymphoid
1
2013
8
0.100
 Why?
Germinal Center
1
2013
29
0.100
 Why?
RNA Splicing
3
2021
43
0.100
 Why?
Retrospective Studies
1
2025
6819
0.090
 Why?
DNA-Binding Proteins
1
2015
423
0.090
 Why?
Genetic Heterogeneity
1
2012
20
0.090
 Why?
Cell Transformation, Neoplastic
1
2013
187
0.090
 Why?
Acetyltransferases
1
2011
18
0.090
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2011
27
0.090
 Why?
Antineoplastic Agents
3
2018
1232
0.090
 Why?
RNA, Messenger
1
2015
1133
0.090
 Why?
Chromosomes, Human, Pair 17
1
2011
35
0.090
 Why?
Cell Proliferation
3
2022
1031
0.090
 Why?
DNA, Neoplasm
3
2018
146
0.090
 Why?
Multivariate Analysis
3
2021
598
0.080
 Why?
TOR Serine-Threonine Kinases
1
2010
83
0.080
 Why?
Remission Induction
2
2021
221
0.080
 Why?
Phenotype
3
2022
803
0.080
 Why?
Tumor Suppressor Protein p53
1
2011
228
0.080
 Why?
Clone Cells
2
2021
76
0.080
 Why?
MicroRNAs
1
2013
397
0.070
 Why?
DNA
1
2012
535
0.070
 Why?
Alleles
2
2021
277
0.070
 Why?
Transcriptional Activation
2
2021
128
0.070
 Why?
Spliceosomes
2
2021
10
0.070
 Why?
Follow-Up Studies
3
2020
2318
0.070
 Why?
Genomic Instability
2
2018
88
0.060
 Why?
Epigenomics
2
2017
76
0.060
 Why?
Risk Factors
3
2021
4017
0.060
 Why?
Loss of Heterozygosity
2
2018
78
0.060
 Why?
Disease-Free Survival
2
2019
466
0.060
 Why?
Treatment Outcome
4
2019
5595
0.060
 Why?
Chromosomes, Human, Pair 20
2
2014
11
0.050
 Why?
Protein Binding
2
2017
670
0.050
 Why?
Liver
2
2022
1150
0.050
 Why?
Genotype
2
2017
563
0.050
 Why?
Dexamethasone
2
2019
429
0.050
 Why?
Histones
2
2016
318
0.050
 Why?
Proportional Hazards Models
2
2015
445
0.050
 Why?
Janus Kinase 1
1
2021
16
0.050
 Why?
Janus Kinase 2
1
2021
27
0.040
 Why?
Gene Rearrangement
1
2022
76
0.040
 Why?
Nitriles
1
2021
55
0.040
 Why?
Organoids
1
2021
41
0.040
 Why?
Microarray Analysis
2
2012
69
0.040
 Why?
Syndecan-1
1
2021
73
0.040
 Why?
Polymerase Chain Reaction
2
2013
452
0.040
 Why?
Chromosome Mapping
2
2011
145
0.040
 Why?
Biomarkers, Pharmacological
2
2011
26
0.040
 Why?
Cell Line
2
2015
1016
0.040
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
 Why?
Cell Movement
1
2022
279
0.040
 Why?
Alternative Splicing
1
2021
61
0.040
 Why?
Pyrazoles
1
2021
123
0.040
 Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
 Why?
Gene Expression
2
2013
618
0.040
 Why?
Pyrimidines
1
2021
205
0.040
 Why?
Phosphoproteins
1
2021
117
0.040
 Why?
Lymphoma, Follicular
1
2020
27
0.040
 Why?
Prospective Studies
2
2016
2411
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
12
0.040
 Why?
Recurrence
1
2021
694
0.040
 Why?
Maintenance Chemotherapy
1
2019
52
0.040
 Why?
Young Adult
2
2021
4511
0.040
 Why?
Syndrome
1
2019
248
0.040
 Why?
Transcription Elongation, Genetic
1
2017
4
0.030
 Why?
Physical Chromosome Mapping
1
2017
7
0.030
 Why?
Genetic Drift
1
2017
3
0.030
 Why?
Gene Knockdown Techniques
1
2018
109
0.030
 Why?
Caspases
1
2018
101
0.030
 Why?
Genetic Loci
1
2017
48
0.030
 Why?
Unfolded Protein Response
1
2017
35
0.030
 Why?
Xenograft Model Antitumor Assays
1
2018
228
0.030
 Why?
Mitosis
1
2017
86
0.030
 Why?
Molecular Targeted Therapy
1
2018
138
0.030
 Why?
Genetic Association Studies
1
2017
124
0.030
 Why?
Genetic Structures
1
2016
1
0.030
 Why?
Risk
1
2017
306
0.030
 Why?
Comparative Genomic Hybridization
1
2016
38
0.030
 Why?
Virus Integration
1
2016
9
0.030
 Why?
Algorithms
1
2020
667
0.030
 Why?
Regulatory Sequences, Nucleic Acid
1
2016
41
0.030
 Why?
Computational Biology
1
2018
209
0.030
 Why?
Nuclear Proteins
1
2017
250
0.030
 Why?
Immunosuppressive Agents
1
2017
253
0.030
 Why?
Flow Cytometry
1
2017
400
0.030
 Why?
Antibodies, Monoclonal
1
2019
477
0.030
 Why?
Minor Histocompatibility Antigens
1
2015
19
0.030
 Why?
MafB Transcription Factor
1
2015
9
0.030
 Why?
Proto-Oncogene Proteins c-maf
1
2015
19
0.030
 Why?
Tumor Microenvironment
1
2017
274
0.030
 Why?
Cytidine Deaminase
1
2015
13
0.030
 Why?
Amino Acid Sequence
1
2016
563
0.030
 Why?
RNA Stability
1
2015
29
0.030
 Why?
Chromosomes, Human, Pair 16
1
2014
18
0.030
 Why?
Patient Selection
1
2016
273
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2015
55
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2014
12
0.030
 Why?
Cytogenetic Analysis
1
2014
79
0.030
 Why?
Ribonucleoproteins, Small Nuclear
1
2014
5
0.030
 Why?
Time Factors
1
2021
2991
0.030
 Why?
Introns
1
2014
51
0.030
 Why?
Single-Cell Analysis
1
2014
72
0.030
 Why?
Methylation
1
2014
127
0.030
 Why?
Base Sequence
1
2015
620
0.030
 Why?
Protein Isoforms
1
2014
124
0.030
 Why?
Down-Regulation
1
2015
344
0.030
 Why?
High-Throughput Screening Assays
1
2013
39
0.030
 Why?
Molecular Sequence Data
1
2015
759
0.030
 Why?
Protein Structure, Tertiary
1
2014
252
0.030
 Why?
HeLa Cells
1
2014
243
0.030
 Why?
Osteonectin
1
2013
10
0.030
 Why?
Chromosomes, Human, Pair 7
1
2013
29
0.020
 Why?
Karyotyping
1
2013
77
0.020
 Why?
Azacitidine
1
2013
39
0.020
 Why?
Transforming Growth Factor beta1
1
2013
61
0.020
 Why?
Mass Spectrometry
1
2014
294
0.020
 Why?
Homologous Recombination
1
2013
45
0.020
 Why?
Disease Models, Animal
1
2018
1517
0.020
 Why?
Early Detection of Cancer
1
2014
190
0.020
 Why?
Apoptosis
1
2018
1139
0.020
 Why?
Validation Studies as Topic
1
2012
10
0.020
 Why?
Tumor Suppressor Proteins
1
2013
130
0.020
 Why?
Gene Library
1
2012
40
0.020
 Why?
Laboratories
1
2012
21
0.020
 Why?
Hemizygote
1
2011
6
0.020
 Why?
Predictive Value of Tests
1
2014
934
0.020
 Why?
Animals
2
2018
13526
0.020
 Why?
Drug Resistance, Neoplasm
1
2013
350
0.020
 Why?
Bone Marrow
1
2013
359
0.020
 Why?
Breast Neoplasms
1
2020
1222
0.020
 Why?
Vincristine
1
2010
89
0.020
 Why?
Prednisolone
1
2010
56
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
412
0.020
 Why?
Cluster Analysis
1
2010
237
0.020
 Why?
Precancerous Conditions
1
2010
87
0.020
 Why?
Adolescent
1
2021
6907
0.020
 Why?
Cyclophosphamide
1
2010
178
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
136
0.020
 Why?
Clinical Trials as Topic
1
2012
466
0.020
 Why?
Stem Cell Transplantation
1
2010
191
0.020
 Why?
Child
1
2021
7379
0.020
 Why?
Models, Biological
1
2012
737
0.020
 Why?
Up-Regulation
1
2010
456
0.020
 Why?
Doxorubicin
1
2010
247
0.020
 Why?
Sex Factors
1
2011
747
0.020
 Why?
Risk Assessment
1
2013
1368
0.020
 Why?
Prevalence
1
2011
1034
0.020
 Why?
Mice
1
2018
5982
0.020
 Why?
Wardell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (266) concept(s)
_
Co-Authors Expand Description
See all (31) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department